These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 33512715)

  • 21. Australian women's self-perceived barriers to participation in cervical cancer screening: A systematic review.
    Nagendiram A; Bougher H; Banks J; Hall L; Heal C
    Health Promot J Austr; 2020 Sep; 31(3):343-353. PubMed ID: 31353682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum].
    Göktuğ Kadıoğlu B; Çınar Tanrıverdi E; Alay H; Uçar M
    Mikrobiyol Bul; 2018 Oct; 52(4):367-375. PubMed ID: 30522422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The comparative and cost-effectiveness of HPV-based cervical cancer screening algorithms in El Salvador.
    Campos NG; Maza M; Alfaro K; Gage JC; Castle PE; Felix JC; Cremer ML; Kim JJ
    Int J Cancer; 2015 Aug; 137(4):893-902. PubMed ID: 25639903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using self-collection HPV testing to increase engagement in cervical cancer screening programs in rural Guatemala: a longitudinal analysis.
    Gottschlich A; Rivera-Andrade A; Bevilacqua K; Murchland AR; Isak E; Alvarez CS; Ogilvie G; Carey TE; Prince M; Dean M; Mendoza-Montano C; Meza R
    BMC Public Health; 2020 Sep; 20(1):1406. PubMed ID: 32933512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 'I'm a bit of a champion for it actually': qualitative insights into practitioner-supported self-collection cervical screening among early adopting Victorian practitioners in Australia.
    Zammit C; Creagh N; Nightingale C; McDermott T; Saville M; Brotherton J; Kelaher M
    Prim Health Care Res Dev; 2023 Apr; 24():e31. PubMed ID: 37185205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge, attitudes, and practices of cervical Cancer screening among HIV-positive and HIV-negative women participating in human papillomavirus screening in rural Zimbabwe.
    Fitzpatrick M; Pathipati MP; McCarty K; Rosenthal A; Katzenstein D; Chirenje ZM; Pinsky B
    BMC Womens Health; 2020 Jul; 20(1):153. PubMed ID: 32711530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
    Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
    BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
    Touch S; Oh JK
    BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Knowledge, Attitudes and Practices of Sudanese Women Regarding the Pap Smear Test and Cervical Cancer.
    Almobarak AO; Elbadawi AA; Elmadhoun WM; Elhoweris MH; Ahmed MH
    Asian Pac J Cancer Prev; 2016; 17(2):625-30. PubMed ID: 26925654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer screening program based on primary DNA-HPV testing in a Brazilian city: a cost-effectiveness study protocol.
    Teixeira JC; Vale DB; Bragança JF; Campos CS; Discacciati MG; Zeferino LC
    BMC Public Health; 2020 Apr; 20(1):576. PubMed ID: 32345284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women's experiences of the renewed National Cervical Screening Program in Australia 12 months following implementation: a qualitative study.
    Dodd RH; Mac OA; McCaffery KJ
    BMJ Open; 2020 Jul; 10(7):e039041. PubMed ID: 32665351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attitudes and factors affecting acceptability of self-administered cervicovaginal sampling for human papillomavirus (HPV) genotyping as an alternative to Pap testing among multiethnic Malaysian women.
    Ma'som M; Bhoo-Pathy N; Nasir NH; Bellinson J; Subramaniam S; Ma Y; Yap SH; Goh PP; Gravitt P; Woo YL
    BMJ Open; 2016 Aug; 6(8):e011022. PubMed ID: 27491667
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Zammit CM; Creagh NS; McDermott T; Smith MA; Machalek DA; Jennett CJ; Prang KH; Sultana F; Nightingale CE; Rankin NM; Kelaher M; Brotherton JML
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporation of human papillomavirus self-sampling into the revised National Cervical Screening Program: a qualitative study of GP experiences and attitudes in rural New South Wales.
    Foo YM; Goswami P; Grogin J; Hargan E; Thangarajah M; Dutton T; Mendel S; Bailey J
    Aust J Prim Health; 2021 Aug; 27(4):284-290. PubMed ID: 33985644
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefits, harms and cost-effectiveness of cancer screening in Australia: an overview of modelling estimates.
    Lew JB; Feletto E; Wade S; Caruana M; Kang YJ; Nickson C; Simms KT; Procopio P; Taylor N; Worthington J; Smith D; Canfell K
    Public Health Res Pract; 2019 Jul; 29(2):. PubMed ID: 31384886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The clinician's view: role of human papillomavirus testing in the American Society for Colposcopy and Cervical Pathology Guidelines for the management of abnormal cervical cytology and cervical cancer precursors.
    Cox JT;
    Arch Pathol Lab Med; 2003 Aug; 127(8):950-8. PubMed ID: 12952506
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Thematic Analysis of Attitudes Toward Changes to Cervical Screening in Australia.
    Dodd RH; Obermair HM; McCaffery KJ
    JMIR Cancer; 2019 Apr; 5(1):e12307. PubMed ID: 30973340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Importance of addition of HPV DNA testing to the cytology based cervical cancer screening and triage of findings with p16/Ki67 immunocytochemistry staining in 35 and 45 years old women LIBUSE trial data analysis.
    Sláma J; Dvořák V; Trnková M; Skřivánek A; Hurdálková K; Ovesná P; Nováčková M
    Ceska Gynekol; 2020; 85(6):368-374. PubMed ID: 33711896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.